Publications

The Development and Validation of the Smell-Qx Questionnaire, Based on a Systematic Review of the Literature and the COMET Initiative on the Development of Core Outcome Sets for Clinical Trials in Olfactory Disorders.

Lechner M , Fjaeldstad A , Rehman U , Liu J , Boniface D , Boardman J , Boak D , Altundag A , Frasnelli J , Gane S , Holbrook E , Hsieh J , Huart C , Konstantinidis I , Landis BN , Lund VJ , Macchi A , Mori E , Mueller C , Mullol J , Negoias S , Patel ZM , Pinto JM , Poletti S , Ramakrishnan V , Rombaux P , Vodicka J , Welge-Luessen A , Whitcroft KL , Yan C , Philpott C , Hummel T
International forum of allergy & rhinology - May 2025

Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.

Yaldizli Ö , Benkert P , Achtnichts L , Bar-Or A , Bohner-Lang V , Bridel C , Comabella M , Findling O , Disanto G , Finkener S , Gobbi C , Granziera C , Herwerth M , Hoepner R , Horakova D , Kamber N , Khalil M , Kunz P , Lalive P , Linker R , Lorscheider J , Müller S , Oechtering J , Pettypool V , Piehl F , Pot C , Roth P , Théaudin M , Tintore M , Tur C , Uffer D , Uginet M , Vehoff J , Wiendl H , Ziemssen T , Zecca C , Salmen A , Leppert D , Derfuss T , Kappos L , Hemkens LG , Janiaud P , Kuhle J
Multiple sclerosis (Houndmills, Basingstoke, England) - Apr 2025

Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis.

Müller J , Sharmin S , Lorscheider J , Ozakbas S , Karabudak R , Horakova D , Weinstock-Guttman B , Shaygannejad V , Etemadifar M , Alroughani R , Patti F , Eichau S , Prat A , Lugaresi A , Tomassini V , Kermode AG , Amato MP , Turkoglu R , Altintas A , Buzzard K , Soysal A , van der Walt A , Butzkueven H , Blanco Y , Gerlach O , Khoury SJ , Barnett M , John N , Lechner-Scott J , Foschi M , Surcinelli A , van Pesch V , Prevost J , Sa MJ , Maimone D , D'hooghe M , Hughes S , Hodgkinson S , McGuigan C , Cartechini E , Taylor B , Spitaleri D , Slee M , McCombe P , Yamout B , Benkert P , Kuhle J , Kappos L , Roos I , Kalincik T , , Havrdova EK , Girard M , Duquette P , Fabis-Pedrini M , Carroll WM , Skibina O , Gouider R , Mrabet S , Ramo-Tello C , Solaro C , Habek M , Van Wijmeersch B , Ampapa R , Macdonell R , Oreja-Guevara C , de Gans K , Laureys G , Oh J , Garber J , Gray O , Agüera-Morales E , Sanchez-Menoyo JL , Castillo-Triviño T , Grigoriadis N , Petersen T , Hardy TA , Vucic S , Reddel S , Ramanathan S , Al-Asmi A , Simu M , Baghbanian SM , Poehlau D , Al-Harbi T , Rojas JI , Deri N , Lalive P , Cambron M , Csepany T , Shuey N , Willekens B , Shaw C , Decoo D , Massey J , Yaldizli Ö , Derfuss T , Granziera C
JAMA neurology - Apr 2025

Targeted radioligand therapy: physics and biology, internal dosimetry and other practical aspects during Lu/Ac treatment in neuroendocrine tumors and metastatic prostate cancer.

Dadgar H , Pashazadeh A , Norouzbeigi N , Assadi M , Al-Balooshi B , Baum RP , Al-Ibraheem A , Haidar M , Beheshti M , Geramifar P , Vali R , Mohammadi S , Dash S , Malasani V , Cimini A , Ricci M , Esmail AA , Murad S , Marafi F , Treglia G , Khalaf AN , Anwar FM , Usmani S , Omar Y , Muhsin H , Tyurin IE , Zakhary A , Al-Sebaie S , Cortes DM , AlHashim M , Arabi H , Zaidi H
Theranostics - 2025